Rici Healthcare Holdings Limited announced unaudited consolidated earnings results for the six months ended June 30, 2017. For the six months period, the company’s revenue for the six months ended June 30, 2017 amounted to approximately RMB 435.881 million, representing an increase of 11.8% from approximately RMB 390.050 million for the corresponding period in 2016. Operating loss was RMB 32.432 million against operating profit of RMB 8.111 million a year ago. Loss before income tax was RMB 55.341 million against RMB 2.262 million a year ago. Loss attributable to owners of the company amounted to approximately RMB 39.440 million, representing an increase of 264.8% from approximately RMB 10.802 million for the corresponding period in 2016. Basic and diluted loss per share for loss attributable to owners of the company was RMB 0.02 against RMB 10.2 a year ago. Adjusted EBITDA for the six months ended June 30, 2017 was approximately RMB 50.966 million, representing a decrease of 36.9% from approximately RMB 80.776 million for the corresponding period in 2016, mainly due to the increase of staff costs with the change of remuneration system. Net cash used in operating activities was RMB 64.975 million against net cash generated from operating activities of RMB 17.212 million a year ago. For the reporting period, the group incurred capital expenditures of RMB 138.6 million (as at December 31, 2016 was RMB 95.9 million), primarily due to purchases of medical equipment for the company’s new medical examination centers and obstetrics and gynecology specialty hospitals.